Aspartame decreases evoked extracellular dopamine levels in the rat brain: An in vivo voltammetry study

被引:20
作者
Bergstrom, Brian P. [1 ]
Cummings, Deirdre R. [1 ]
Skaggs, Tricia A. [1 ]
机构
[1] Muskingum Coll, Dept Biol, Neurosci Program, New Concord, OH 43762 USA
关键词
dopamine; voltammetry; aspartame; striatum; release; uptake;
D O I
10.1016/j.neuropharm.2007.09.009
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Conflicting reports exist concerning the effect aspartame (APM, L-aspartyl-L-phenylalanine methyl ester) has upon brain biogenic amines. In the following study, in vivo voltammetry was utilized to measure evoked extracellular dopamine (DA) levels in the striatum of rats in order to assess APM's effect. Time-course experiments revealed a significant decline in evoked extracellular DA levels within I h of a single systemic dose (500 mg/kg i.p.) when compared to vehicle-injected controls. The effect was frequency dependent and showed a significant decrease utilizing high frequency stimulation parameters (50 and 60 Hz). In order to further determine APM's potential to alter evoked extracellular DA levels, extended stimulation periods were employed to deplete releasable stores both before and after APM administration in intact and 6-OHDA partially lesioned animals. The extended stimulation periods were applied at 60 Hz for 2,5,10 and 20 s durations. APM decreased DA levels under these conditions in both intact and 6-OHDA partially lesioned animals by an average of 34% and 51%, respectively. Kinetic analysis performed on frequency series indicated that the diminished DA levels corresponded to a significant reduction in DA release. These findings suggest that APM has a relatively potent effect of decreasing evoked extracellular DA levels when administered systemically under the conditions specified. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:967 / 974
页数:8
相关论文
共 51 条
[1]   TIME COURSE OF ADAPTATIONS IN DOPAMINE BIOSYNTHESIS, METABOLISM, AND RELEASE FOLLOWING NIGROSTRIATAL LESIONS - IMPLICATIONS FOR BEHAVIORAL RECOVERY FROM BRAIN INJURY [J].
ALTAR, CA ;
MARIEN, MR ;
MARSHALL, JF .
JOURNAL OF NEUROCHEMISTRY, 1987, 48 (02) :390-399
[2]   INHIBITION BY L-PHENYLALANINE OF TYROSINE TRANSPORT BY SYNAPTOSOMAL PLASMA-MEMBRANE VESICLES - IMPLICATIONS IN THE PATHOGENESIS OF PHENYLKETONURIA [J].
ARAGON, MC ;
GIMENEZ, C ;
VALDIVIESO, F .
JOURNAL OF NEUROCHEMISTRY, 1982, 39 (04) :1185-1187
[3]   Partial, graded losses of dopamine terminals in the rat caudate-putamen: an animal model for the study of compensatory adaptation in preclinical parkinsonism [J].
Bergstrom, BP ;
Schertz, KE ;
Weirick, T ;
Nafziger, B ;
Takacs, SA ;
Lopes, KO ;
Massa, KJ ;
Walker, QD ;
Garris, PA .
JOURNAL OF NEUROSCIENCE METHODS, 2001, 106 (01) :15-28
[4]   METABOLISM OF ASPARTAME AND ITS L-PHENYLALANINE METHYL-ESTER DECOMPOSITION PRODUCT BY THE PORCINE GUT [J].
BURGERT, SL ;
ANDERSEN, DW ;
STEGINK, LD ;
TAKEUCHI, H ;
SCHEDL, HP .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1991, 40 (06) :612-618
[5]   Microelectrodes for the measurement of catecholamines in biological systems [J].
Cahill, PS ;
Walker, QD ;
Finnegan, JM ;
Mickelson, GE ;
Travis, ER ;
Wightman, RM .
ANALYTICAL CHEMISTRY, 1996, 68 (18) :3180-3186
[6]  
Cooper J.R., 1996, BIOCH BASIS NEUROPHA, V7th
[7]   NEUROBIOCHEMICAL ALTERATIONS INDUCED BY THE ARTIFICIAL SWEETENER ASPARTAME (NUTRASWEET) [J].
COULOMBE, RA ;
SHARMA, RP .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1986, 83 (01) :79-85
[8]   CATECHOLAMINE INNERVATION OF BASAL FOREBRAIN .4. TOPOGRAPHY OF DOPAMINE PROJECTION TO BASAL FOREBRAIN AND NEOSTRIATUM [J].
FALLON, JH ;
MOORE, RY .
JOURNAL OF COMPARATIVE NEUROLOGY, 1978, 180 (03) :545-+
[9]  
FDA, 1984, FED REGISTER, V49, P6672
[10]   ACUTE EFFECTS OF ASPARTAME ON LARGE NEUTRAL AMINO-ACIDS AND MONOAMINES IN RAT-BRAIN [J].
FERNSTROM, JD ;
FERNSTROM, MH ;
GILLIS, MA .
LIFE SCIENCES, 1983, 32 (14) :1651-1658